Molecule Structure

Scientific Name

Lomustine

Description of the Drug

Lomustine is an alkylating agent used as a part of chemotherapeutic regimens for the treatment of primary and metastatic brain tumors as well as refractory or relapsed Hodgkin’s disease in addition to surgical and/or radiotherapeutic treatments.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01206

Brand Name(s)

Ccnu, Ceenu, Gleostine

Company Owner(s)

Corden Pharma Latina Spa

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
DNA NUCLEIC-ACID INHIBITOR CHEMBL2311221

Unichem Links

Atlas lomustine
SureChEMBL SCHEMBL3995
PharmGKB PA164749407
Human Metabolome Database HMDB0015337
WDI LOMUSTINE
DrugBank DB01206
PubChem: Thomson Pharma 15121730
PubChem 3950
Nikkaji J3.122D
BindingDB 50247919
EPA CompTox Dashboard DTXSID2023222
DrugCentral 1596
ChemicalBook CB5123021
Guide to Pharmacology 7214
GSRS 9266e5a5-a19d-4a11-8ce1-56fb5553d5b2
rxnorm GLEOSTINE LOMUSTINE
KEGG Ligand C07079
ChEBI 6520
ZINC ZINC000003831006